# A Phase III Trial of e-TNS for the Acute Treatment of Migraine

> **NCT03465904** · NA · COMPLETED · sponsor: **Cefaly Technology** · enrollment: 607 (actual)

## Conditions studied

- Migraine

## Interventions

- **DEVICE:** Verum Cefaly® Abortive Program device
- **DEVICE:** Sham Cefaly® Abortive Program device

## Key facts

- **NCT ID:** NCT03465904
- **Lead sponsor:** Cefaly Technology
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-10
- **Primary completion:** 2019-01-11
- **Final completion:** 2019-01-11
- **Target enrollment:** 607 (ACTUAL)
- **Last updated:** 2024-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03465904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03465904, "A Phase III Trial of e-TNS for the Acute Treatment of Migraine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03465904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*